SEQUENT SCIENTIFIC
|
The Current P/E Ratio of SEQUENT SCIENTIFIC is 150.53.
Share Price | ₹139.3 | Mar 18,2025 |
Market Cap | ₹3,485.4 Cr | |
Earnings-TTM | ₹23.2 Cr | TTM-Consolidated Results |
Price/Earnings | 150.53x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SEQUENT SCIENTIFIC
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹3,485.4 Cr] as on Mar 18,2025
(/) Earnings [ ₹23.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 150.53x ]
Thus, for SEQUENT SCIENTIFIC , the investors are currently willing to pay 150.53 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SEQUENT SCIENTIFIC !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SEQUENT SCIENTIFIC over the last five years.
Historical PE (Price/Earnings) ratio chart of SEQUENT SCIENTIFIC
PE Ratio Performance Analysis for SEQUENT SCIENTIFIC
- SEQUENT SCIENTIFIC 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 34.29x.
- SEQUENT SCIENTIFIC 's operated at median p/e ratio of 27.61x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SEQUENT SCIENTIFIC 's p/e ratio peaked in Mar2022 at 81.14x.
- SEQUENT SCIENTIFIC 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does SEQUENT SCIENTIFIC 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SEQUENT SCIENTIFIC | 23.15 | 150.53 | 3,485.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.53 | 419,548.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 74.21 | 153,385.0 |
CIPLA LTD | 5,000.43 | 24.37 | 121,845.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 56.99 | 106,123.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 17.90 | 97,189.0 |
MANKIND PHARMA LTD | 2,050.73 | 43.18 | 88,557.9 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.79 | 90,873.0 |
LUPIN LTD | 2,892.10 | 32.13 | 92,919.8 |
AUROBINDO PHARMA LTD | 3,500.25 | 18.87 | 66,045.9 |
ABBOTT INDIA LTD | 1,334.46 | 47.45 | 63,317.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SEQUENT SCIENTIFIC 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.90x |
Max industry PE | 150.53x |
Median industry PE | 36.53x |
Average industry PE | 47.45x |
You may also like the below Video Courses